학술논문
Randomized clinical trial: A double-blind, proof-of-concept, phase 2 study evaluating the efficacy and safety of vonoprazan 20 or 40 mg versus esomeprazole 40 mg in patients with symptomatic gastro-esophageal reflux disease and partial response to a healing dose of a proton-pump inhibitor
Document Type
Article
Author
Source
In: Neurogastroenterology and Motility . (Neurogastroenterology and Motility, January 2023, 35(1))
Subject
Language
English
ISSN
13652982
13501925
13501925